Sorrento Therapeutics, Inc.
Biotechnology company · San Diego, California, United States
Sorrento Therapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2006. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $4.8 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $1.9 million sold in a notice filed in 2013.
What does Sorrento Therapeutics do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $4.8 million in total (2010 to 2014).
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $1.9 million sold (2013).
Frequently asked questions about Sorrento Therapeutics
Where is Sorrento Therapeutics headquartered?
Sorrento Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Sorrento Therapeutics do?
Sorrento Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Sorrento Therapeutics founded?
The earliest incorporation on record for Sorrento Therapeutics, Inc. is in 2006, according to public company registers.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.